Irisin is produced by a proteolytic cleavage of fibronectin type III domain-containing protein 5 (FNDC5) and has emerged as a potential mediator of exerciseinduced energy metabolism. The purpose of this study was to review the results of studies that investigated irisin responses to acute and chronic exercise and provide an update. A comprehensive search in the databases of MED-LINE was performed (74 exercise studies). The focus of the analysis was on data concerning FNDC5 mRNA expression in skeletal muscle and circulating irisin concentration relatively to exercise mode, intensity, frequency and duration and the characteristics of the sample used. Circulating irisin levels may either not relate to FNDC5 transcription or expression of the later precedes irisin rise in the blood. Acute speed/strength and endurance exercise protocols represent potent stimuli for irisin release if they are characterized by adequate intensity and/or duration. There are no reports regarding irisin responses to field sport activities. Although animal studies suggest that irisin may also respond to systematic exercise training, the majority of human studies has produced contradictory results. Certain methodological issues need to be considered here such as the analytical assays used to measure irisin concentration in the circulation. Results may also be affected by subjects' age, conditioning status and exercise intensity. The role of irisin as a moderator of energy metabolism during exercise remains to be seen.
Introduction
Physical activity (PA) and/or exercise are widely accepted as important interventions not only for the prevention and treatment of various metabolic diseases such as obesity and type 2 diabetes mellitus [1] . Acute and chronic exercise induces extensive metabolic adaptations in skeletal muscle and other organs (e.g. adipose tissue and liver) such as mitochondrial biogenesis [2] . Exercise exerts its effects through various molecular pathways and myokines, which not only act on muscle itself via an autocrine/paracrine manner but also mediate the interaction of muscle with other organs through endocrine mechanisms [2, 3] . A recently discovered myokine named irisin has been linked to body mass regulation [4] . Irisin, a 112-amino acid glycosylated protein-hormone with a molecular weight of ~12-32 kDa, is a dimer consisting of an N-terminal fibronectin III (FNIII)-like domain that possible binds on fibronectin type III domain-containing protein 5 (FNDC5) receptors [5] .
Exercise upregulates the expression of peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α), a transcriptional coactivator that mediates body's adaptation to exercise by increasing mitochondria biogenesis, insulin sensitivity, energy expenditure and angiogenesis [6, 7] . PGC-1α in muscle may trigger a proteolytic cleavage of FNDC5 (a membrane protein) to produce irisin that is subsequently released into the circulation [4, 8] . Irisin is also expressed in hippocampus in a PGC-1α-dependent manner during exercise where it triggers the expression of several neuroprotective genes [9] . Muscle-or brainderived irisin release may regulate exercise effects on the body's energy metabolism via an endocrine action on other tissues, such as adipocytes, heart, bone, kidney, immune system, pancreas, liver and ovaries [10, 11] .
Irisin may promote the expression of uncoupling protein 1 (UCP1) in white adipose tissue (WAT), probably through p38 mitogen-activated protein kinase (MAPK) signaling, a process called browning, thereby elevating energy expenditure and improving metabolic profile [4, 12] (Figure 1 ). Consequently, irisin could promote leanness that ultimately may aid the fight against obesity, type 2 diabetes, insulin resistance (IR) and other metabolic diseases [13] [14] [15] . Irisin resistance, i.e. a compensatory rise in circulating irisin, has been associated with IR [16] . Reduced circulating irisin levels have been systematically reported in patients with chronic kidney disease, preeclamptic women during gestation, type 2 diabetics and osteoporotic patients [11] . The observation of increased serum irisin levels in healthy centenarians suggested that successful aging may be related to irisin secretion [17] , which is in line with the age-dependent decline of PGC-1α expression [18] .
The exercise-induced upregulation of PGC-1α and the positive correlation of plasma irisin with various obesityrelated parameters, disorders and inflammation (e.g. waist-to-hip ratio, body mass index, body fat, C-reactive protein, etc.) [19, 20] made researchers hypothesize that irisin may be a positive regulator of exercise effects on weight management and inflammation [21] . Irisin has also been suspected to mediate various beneficial exercise effects on metabolic regulation such as the upregulation of energy expenditure through the induction of UCP1 in WAT, a process that promotes leanness [4] . In fact, PGC1-α overexpressed by muscle cells secrete one or more molecules that can induce a thermogenic gene program in subcutaneous adipocytes that results in formation of beige adipocytes (known as browning) via a direct muscle-fat cross talk [4] . When researchers searched for proteins as potential PGC1-α target genes in muscle and likely to be secreted, Bostrom et al. [4] noted that out of five candidate protein molecules, only FNDC5 was capable of inducing UCP1 mRNA and other brown fat genes' expression. Moreover, immunohistochemistry of FNDC5-treated UCP1positive cells showed a robust increase in multilocular lipid droplets and areas of higher mitochondrial density [4] . Thus, irisin emerged as a promising therapeutic tool to treat metabolic disorders, and its name was derived from the ancient messenger Greek goddess iris to convey its role as muscle's messenger to fat cells. If this hypothesis holds, then irisin should respond to various acute and chronic exercise protocols. However, whether an exerciseinduced effect on irisin regulation exists or not remains a rather controversial issue because experimental data vary among studies giving rise to a debate that focuses on (i) whether irisin is involved in human metabolism, Irisin synthesis and release upon skeletal muscle stimulation by exercise or under conditions of cold exposure. Following activation of PGC-1a, expression of FDNC5 (located at cellular membrane) is upregulated and then undergoes proteolytic cleavage to give rise to irisin, which then is released into the circulation. Thereafter, irisin may act on fat tissue to induce the formation of beige adipocytes and increase the expression of UCP-1 or increase the of phosphorylation AMPK in skeletal muscle. PGC-1α, peroxisome proliferator-activated receptor γ coactivator 1α; FNDC5, fibronectin type III domain-containing protein 5; UCP-1, uncoupling protein-1; AMPK, AMP-activated protein kinase; ?, unclear.
(ii) whether exercise is a potent stimulus for irisin production, (iii) what are the physiological implications of irisin in exercising humans, (iv) whether exercise induces FNDC5 expression in various tissues and (v) the adequacy of the available methods to quantify circulating irisin in human biological samples. The next sections are describing the current knowledge on the relationship between exercise and irisin as well as evidence on irisin's role(s) and measurement.
Irisin responses to exercise
Irisin responses to acute exercise FNDC5 mRNA and plasma irisin did in fact increase in mouse and human muscle following exercise, and this rise was accompanied by positive metabolic adaptations suggesting that following proteolytic cleavage of FNDC5, irisin is released into circulation and probably reaches fat cells where it potentially binds to a receptor to induce browning and heat production [4] . Shortly after, this hypothesis was challenged by another group [21] , who reported no exercise-induced change of irisin in skeletal muscle suggesting that FNDC5 in muscle is not exerciseinduced. Since then, more in vivo and in vitro studies investigated the acute irisin responses to various exercise models. This section will describe in detail the effects of a single acute bout of several types of exercise on irisin metabolism. A recent meta-analysis concluded that acute exercise elicits a substantial rise of circulating irisin concentration that was related to participants' fitness levels [22] . However, this meta-analysis included only 10 published articles, and not all types of exercises were represented adequately [22] .
Acute responses to speed/strength exercise
Speed/strength-type exercise protocols (Table 1) are characterized by efforts of maximal intensity and short duration. Sprint runs induced a marked rise of serum irisin postexercise in moderately trained and untrained males with or without metabolic syndrome [25, 37] . Findings derived from racing greyhound dogs corroborated that sprint-type exercise does increase peripheral irisin levels acutely [29] . In case of sprinting, irisin rise may be related to the decline of muscle ATP, i.e. a state of metabolic need [8] . Acute sprint-type exercise may represent a potent stimulus for irisin release into the circulation as a part of a compensatory mechanism that attempts to defend ATP homeostasis in muscle [8, 29] .
Several studies investigated whether strength-type exercise protocols could alter irisin levels in the blood. When young and old untrained males were subjected to a high-volume resistance exercise protocol for leg extensors only, skeletal muscle FNDC5 increased 1.4-fold in young participants only, whereas serum irisin remained unchanged [23] . By contrast, when young males and females underwent a whole-body resistance exercise protocol (eight exercises for major muscle groups at three to four sets at 10-12 maximal repetitions or RM), FNDC5 remained unchanged in muscle whereas serum irisin increased for 1 h postexercise [25, 27, 28] . Irisin also increased by resistance exercise with partial vascular occlusion in young men, suggesting that it may be implicated in muscle growth-related mechanisms [30] . Wholebody vibration exercise also resulted in marked rise (~10%) of irisin in young untrained females [24] .
These findings suggest that irisin may respond to high-intensity protocols that recruit multiple muscle groups such as sprinting or whole-body resistance exercise independent of age, sex, fitness status and clinical profile. This possibility agrees with a previous report of a positive correlation between irisin and follistatin, which is implicated in muscle growth [47] . Evidence suggests that irisin may even be involved in the regulation of muscle hypertrophy-related signaling [48] . Collectively, brief intense exercise may be a potent stimulus for irisin release in young trained or untrained humans of both sexes. These studies measured irisin levels in plasma and serum samples as well as in skeletal muscle biopsies.
Acute responses to endurance exercise
Endurance exercise (Table 1) is characterized by efforts of long duration and low-to-high intensity representing probably a greater metabolic challenge than other types of exercise. Irisin was found to increase in blood or saliva in response to protocols characterized by a prolonged duration (>45 min) [10, 31-35, 37, 38] and/or moderate-tohigh intensity (>60% of maximal oxygen consumption or VO 2max ) [10, 25, 26, 27, 31, 34, [37] [38] [39] 42] . These increases (12%-123%) peaked in protocols that were characterized by maximal intensity [26, 36, 39] . According to Daskalopoulou et al. [36] , subjects that underwent three different exercise regimes (i.e. maximal or submaximal relative and absolute workload) demonstrated significantly higher levels of irisin at 3 min postexercise compared with preexercise values, in all exercise conditions. These irisin responses have been observed in both genders, as well in children, adolescents, young adults and middle-aged and older individuals as well as in adults with metabolic syndrome independently of training status [10, 25-27, 31, 34, 37-39] . Interestingly, protocols of moderate intensity (≤65% VO 2max ) failed to alter irisin status [23, 28, 37, 39] except in one case [43] . These findings were also corroborated by most animal studies [33, 35, 40] and research that applied exercise mimetics on differentiated C 2 C 12 myotubes [45] . By contrast, in human primary muscle cell cultures, exercise mimetics actually decreased FNDC5 and irisin (Table 1 ) [46] . An irisin decline was also seen in an animal study [41] . One report suggested that obesity may blunt this exercise-induced increase of irisin compared with leans, but this remains to be confirmed by future studies [42] . Interestingly, in three occasions, irisin increased postexercise despite a decline [35] or lack of change [27, 33] of FNDC5 mRNA expression in both human and animal skeletal muscle and despite a marked rise in PGC-1α expression [49] . These observations suggest that either irisin levels in blood may not relate to FNDC5 transcription or FNDC5 expression precedes irisin rise in the circulation. These two alternatives would not be visible if muscle biopsies and blood sampling occurred at the same time point(s) as it happened in the studies described here.
Collectively, results from most human and animal studies suggest that irisin increases in response to endurance exercise depending on the intensity and duration (and/or their combination) of exercise protocols.
Acute responses to interval-type exercise
Interval exercise training ( Table 1) incorporates periods of intense exercise interspersed by resting intervals, and it has been shown to result in high oxygen consumption [50] , substantial enhancement of VO 2max [51] and healthrelated adaptations such as mitochondrial biogenesis [52] and improved antioxidant status [53] . This training methodology is characterized by the intensity and duration of work vs. resting intervals as well as the recovery mode [54] . This type of acute exercise protocol was implemented in only two studies. Both of them indicated that irisin increases by 12%-15% in obese [43] and middle-aged adults with multiple sclerosis [44] .
Responses to in vitro models mimicking acute exercise
Only two studies used in vitro models to mimick acute exercise responses. When adrenalin was applied to differentiated C 2 C 12 myotubes, irisin remained unaltered [45] . By contrast, when forskolin and ionomycin were introduced to human primary muscle cell cultures established from lean, obese prediabetic and type 2 diabetic individuals to simulate exercise, PGC-1a increased (more than doubled), FNDC5 mRNA was reduced by 18% in differentiated muscle cells, irisin in media decreased by 20% whereas PGC-1a expression increased in muscle cells [46] . These discrepancies among these studies may be attributed to the experimental model used.
Conclusions on acute exercise
A total of 35 studies were reviewed to determine whether acute exercise represents a potent stimulus for an irisin rise in the circulation. It appears that all types of acute exercise protocols (i.e. speed/strength, endurance, interval) applied in humans and animals represent potent stimuli for irisin release if they are characterized by adequate intensity and/or duration. The only study that compared resistance exercise with interval-and endurance-type exercise protocols reported that strengthening exercise could induce a greater irisin response than multiple sprints and continuous cardiovascular exercise [25] . However, it would be difficult to directly compare these three different exercise protocols if they are not matched in energy produced and work performed. It would also be interesting to see irisin responses to field sport activities in future studies.
Irisin responses to chronic exercise
The health-related positive adaptations induced by systematic exercise (training) are very well documented especially those that are related to metabolic health, musculoskeletal health and weight management. However, we still have a lot to learn about the systemic, cellular and molecular pathways that regulate these health-promoting adaptations of exercise training. Irisin has emerged as a potential mediator of exercise-induced health benefits as it enhanced health and prolonged life of mice designed to overexpress PGC-1α in skeletal muscle, a response also elicited by exercise training [4] . Although irisin seems to respond to various types of acute exercise, results from chronic exercise studies seem, at least, equivocal so far. However, a meta-analysis that covered the period 2012-2014 (12 studies, three randomized and nine nonrandomized trials) reported that resistance exercise training tends to decrease irisin levels in the circulation whereas endurance exercise training demonstrates only a tendency for a similar effect [55] . However, most reviews so far classified exercise interventions as acute or chronic and endurance or resistance. This is a simplistic approach to describe a wide range of different metabolic challenges posed by various types of exercise interventions, i.e. endurance exercise, strength exercise, sprint-type exercise, interval training and PA interventions. This review will attempt to present all current information on this issue by including studies that examined the effects of all different types of exercise training and PA interventions (67 studies).
Evidence from cross-sectional studies
Results of cross-sectional studies ( Table 2) provided some evidence that irisin may respond to exercise training. Many studies have reported a reverse relationship between irisin responses and training status, i.e. a higher training, exercise capacity or activity level is associated with a lower irisin concentration in the circulation, i.e. lower irisin values in athletes and physically active individuals compared with non-athletes and sedentary individuals [37, 58, 62, 64] . On the other hand, habitual daily PA was positively associated with fitness status with irisin levels in chronic obstructive pulmonary disease (COPD) patients, overweight individuals and healthy controls [61, [63] [64] [65] [66] . It appears that irisin may be positively associated with fitness status in females and inversely in males [64] . However, when trained individuals were compared with untrained ones under conditions of mild cold exposure, the former demonstrated a higher FDNC5 expression in skeletal muscle and similar circulating irisin levels with the later, suggesting that irisin may not participate in adipocyte browning assessed by [18F] fluorodeoxyglucosepositron emission tomography-computed tomography [84] . Although irisin was not measured, the expression of its genetic forerunner FNDC5 was more pronounced in trained cardiac patients as compared with untrained cardiac patients [56] . By contrast, under condition of severe energy restrictions, serum irisin was similar in anorexics with either low or high PA levels [57] and was not correlated with VO 2max values [60] . Furthermore, amenorrhoeic female athletes exhibited lower irisin values than their eumenorrheic counterparts and non-athletes further that a chronic energy deficit state and not fitness status may affect irisin values [59] . It must be mentioned that two recent studies also noted no differences in irisin levels between trained and untrained males and females [67, 105] . Therefore, only 50% of cross-sectional studies suggest that athletes and physically active individuals demonstrate higher circulating irisin levels compared with non-athletes and physically active controls.
Irisin responses to strength exercise training
Studies that examined the effects of speed/strength-type exercise training on irisin responses are shown in Table 2 . Five resistance-type exercise interventions [49, 68-70, 73, 76] of various durations (11-26 weeks), intensities (50%-80% of maximal strength), volumes (≥8 exercises, 2-5 sets/exercise and 7-20 RM/set) and with a frequency of three sessions/week failed to observe a change in either FNDC5 gene expression or circulating irisin concentration, suggesting that this type of training may not be a potent stimulus for irisin adaptation in young and middle-aged males or females. By contrast, four recent investigations clearly showed that strength training elicited a marked rise (20% to fivefold) of circulating irisin in young and old humans as well as in rats [72, 74, 75, 77] . This rise in irisin was accompanied by a fourfold increase in skeletal muscle FNDC5 expression and a threefold elevation of adipose tissue UCP1 expression [75] . This upregulation of irisin in response to strength training seems to be enhanced by ursolic acid supplementation [69] . Two training studies that used vibration as a resistance exercise mode reported also conflicting results. A vibration training protocol of flexor and extensor muscle groups of trunk and lower limbs of older male and female hospitalized patients with stable COPD increased serum irisin posttraining [71] , whereas a 6-week protocol with two sessions/week with isometric exercises in young untrained females failed to alter irisin concentration in the circulation [24] . Collectively, while earlier human and animal studies suggest that irisin does not respond to resistance exercise training, more recent investigations indicate that this type of training increases irisin in the circulation. We need more data to conclude whether muscle strengthening regimens can stimulate the production and release of irisin.
Irisin responses to chronic endurance training
Based on the results derived from cross-sectional studies, one would expect that irisin responds to endurance training regimens. Unfortunately, almost all human training studies ( Table 2) failed to observe a training-induced response of FNDC5 mRNA expression or irisin in the circulation despite the utilization of a wide variety of exercise modes (walking, running, cycling), intensities (60%-90% of peak heart rate), durations (3-21 weeks) and frequencies (2-3 days/week) [23, 49, 68, 74, 79, 85] . On the other hand, three other studies reported a rise in circulating irisin in older adults in response to a cardiovascular training program of moderate intensity [84, 85, 91] . If age is a crucial factor for irisin response to endurance training remains to be seen. Interestingly, results from animal training studies (Table 2) were entirely different with nine of them reporting an increase of serum irisin [40, 78, 83, 87-90, 92, 93] and five reporting no response [35, 80, 81, 82, 86] . Strangely, in studies that showed a positive response to training, irisin increase was not always accompanied by a rise in FNDC5 gene expression [78, 87] . The rise in irisin was paralleled by an increase of irisin and PGC-1a levels in skeletal muscle in only one animal study [89] . Interestingly, in four of the studies that reported a rise in serum irisin, animals were fed a high-fat diet to promote obesity [88] [89] [90] 93] . In these studies, serum irisin was negatively correlated with triglyceride levels, fat mass, total cholesterol levels, IR and restoration of plasma adiponectin [88, 90, 93] . In fact, endurance exercise training in one case rescued irisin's downregulation, a response that was coupled with an elevated activation of adenosine monophosphate-activated protein kinase (AMPK) and a rise in the expression of irisin and PGC-1a in muscle [89] . These results coincide with findings of improved metabolic profile (i.e. insulin sensitivity, fat loss) following pharmacologic administration of irisin in animals [90] .
The reason(s) for these discrepancies among human and animal studies remains to be elucidated. Differences may be attributed to either interspecies variations in irisin response or a higher total training load in animal studies (5 vs. 2-3 sessions/week). Collectively, results from human and animal studies point to different directions, and as such no firm conclusion can be reached on the effects of endurance-type training on irisin responses.
Irisin responses to interval exercise training
Three studies that have examined the effects of interval sprint training on irisin responses (Table 2) have produced conflicting results. Two studies that used an 8-and 9-week sprint interval training intervention with three sessions/week failed to alter irisin levels in the circulation [8, 44] . Similarly, a shorter period of interval sprint training protocol (3 weeks, nine sessions) did not affect plasma irisin levels and muscle FNDC5 gene expression [94] . In line with these findings, elite adolescent tennis (an interval-type activity) athletes monitored during their yearly training cycle exhibited no variation in serum irisin concentration [97] . By contrast, a study that employed an interval exercise program of greater volume (36 sessions) and measured circulating irisin by quantitative mass spectrometry reported a rise of plasma irisin posttraining, suggesting that irisin may respond to higher training volumes [95] . On the other hand, another study that used high-volume sprint training reported a 77% decline in serum irisin following training [96] . Collectively, most studies suggest that interval-type exercise may not trigger an irisin response despite its intense nature.
Irisin responses to exercise training combining various exercise training protocols
So far, we presented studies that employed a single exercise mode as the training stimulus. What if a combination of exercise mode was used to provide a more intense and thorough muscle and energy system recruitment ( Table 2) ? When young obese males and females were subjected to mild circuit resistance exercise training that was combined with moderate cardiovascular activities (3 days/week for a total duration of 12 weeks), no changes were detected in skeletal muscle FNDC5 gene expression and serum irisin levels [46] . Similar results were obtained when untrained middle-aged or obese adults trained with a combination of intense prolonged cycling and wholebody strength training for 21-24 weeks [23, 98, 99] . By contrast, implementation of a similar training combination for 12 weeks resulted in increased FNDC5 mRNA levels in skeletal muscle and reduced irisin in plasma in middleaged untrained males [31] . It appears, so far, that only one out of five studies support the notion that a cross-training training protocol upregulates circulating irisin levels in humans.
Irisin responses to PA interventions
Similarly, to human training studies that utilized endurance-type exercise, investigations that manipulated daily PA levels (usually characterized by a significantly lower intensity but implemented daily) failed to observe changes in circulating irisin levels (Table 2) . Specifically, a study with children engaged in increased PA by adding either 1 or 12 sports units/week over a period of 3 years reported an absence of irisin response postintervention [26] . Similar results were reported also for preadolescents and middle-aged men who were also subjected to increased daily PA through sport participation and leisure time PA, respectively [100, 101] . Animal studies, on the other hand, produced contradictory results. When rats were subjected to voluntary wheel running or standing PA in their cages, irisin in plasma and skeletal muscle failed to change [103, 104] . However, mice fed a high-fat diet and increased their PA through voluntary wheel running upregulated UCP1, PGC-1a and FNDC5 in muscle in response [102] . Hence, it may be concluded that daily PA may not offer a potent stimulus for irisin synthesis and release by skeletal muscle.
The big picture -does irisin has a physiological role in exercise-induced adaptations in humans?
Irisin concentration is most likely regulated by single exercise bouts, as longer training interventions have failed to provide a clear picture, mainly in humans. However, the time frame of exercise-induced irisin responses might be affected by factors such as the age, exercise intensity and/or the individuals' conditioning level. Although irisin's resting values are negatively associated with age in cross-sectional studies [8, 37] , exercise-induced elevations of irisin were not age dependent [37] . Despite individuals with higher PA or cardiovascular conditioning level exhibiting lower resting values of irisin than their sedentary or less fit counterparts, suggesting a negative association between irisin levels and fitness status [37, 62] , no differences were seen among them in response to an exercise bout [37] . Exercise intensity is critical, as most metabolic and physiological adaptations are intensity dependent. However, studies examining the interaction between exercise intensity and irisin release are lacking, and therefore we cannot come to a clear conclusion. Available data indicate significantly greater increases in circulating irisin levels postexercise with maximal workload (VO 2max ) as compared with submaximal workloads [36, 39] .
Irisin is thought to act on subcutaneous WAT to promote browning and thus thermogenesis because FNDC5 overexpression in insulin-resistant animals resulted in fat tissue reduction [4] . Irisin itself has consistently induced browning in brite adipocytes but not in brown adipocytes [7, 106, 107] . Interestingly, irisin induced "browning" of mature human primary adipocytes, elevated cellular thermogenesis and inhibited adipogenesis [108] . Although UCP1 expression and serum irisin increased in response to activation by a PPARα agonist [109] , BAT activity may be unresponsive to exercise, and thus irisin may stimulate brite adipocytes only [110, 111] . Studies suggest that irisin may not act on subcutaneous WAT, but it is rather related to browning at the level of visceral adipose tissue [112, 113] . Some suggest that FNDC5 and not circulating irisin may be involved in the regulation of exercise-induced browning effect in adipose tissue [31, 56, 82] . If irisin is involved in exercise-induced "browning" of fat tissue and increased thermogenesis, then one would expect to see a rise of UCP1 and FNDC5 expression in adipose tissue and muscle, respectively, in response to exercise. Although, increased fitness level has been associated with elevated FNDC5 expression in muscle [56, 57] , systematic exercise training failed to alter FNDC5, PGC-1a or irisin expression in several cases [8, 23, 35, 40, 46, 49, 70, 72, 78-82, 94, 103] and succeeded only in few [31, 87, 89, 92, 102] . A study that measured the expression of UCP1 in human subcutaneous WAT reported that a combination of endurance and resistance exercise training was ineffective to alter UCP1, FNDC5 mRNAs and circulating irisin [31] . Voluntary PA was ineffective to alter FNDC5 expression in WAT and serum irisin levels, but moderate 3-week exercise training increased irisin-dependent browning of WAT in mice [114] . Therefore, and despite the promising results derived from in vitro and animal studies, exercise training studies are highly inconclusive reporting no apparent link between muscle PGC-1a and FNDC5 expression and circulating irisin in humans.
Irisin may also originate from adipose tissue, a tissue that does produce FNDC5 [115] . Irisin secretion from adipose tissue may be reduced in response to systematic exercise training, indicating a discrete regulation of FNDC5/irisin production by skeletal muscle and adipose tissue [115] . In fact, leptin and other myokines may differentially control FNDC5/irisin expression in muscle and fat, suggesting a cross talk between these tissues to regulate exercise-induced fat browning and thermogenesis and thus energy expenditure [115] . In human studies, however, basal FNDC5 protein levels were lower in WAT compared with muscle, suggesting that higher irisin levels in adipose tissue may be attributed to transport from muscle via the circulation or increased release by other tissues [8, 114] . Therefore, one should examine both tissues with respect to exercise-induced irisin responses. In conclusion, the controversy remains regarding the role of irisin in exercise-induced thermogenesis through fat browning.
Recent studies have assigned a potential antiinflammatory role for irisin as well. Irisin seems to provide an anti-inflammatory protection in fat cells [116] probably by modulating the pro-inflammatory activity of immunocompetent cells such as macrophages through downregulation of reactive oxygen species production [117] and downstream pathways such as the TLR4/MyD88 [118] , but human studies are lacking.
A metabolic role for FDNC5 and irisin is also supported by data findings [119] , suggesting that defects of carbohydrate and fat metabolism as well as IR were ameliorated in obese animals and lipolysis was increased by an FDNC5/irisin-dependent mechanism. Irisin has also been implicated metabolically in skeletal muscle itself by two investigations that reported an irisin-dependent rise in AMPK phosphorylation and uptake of glucose and fatty acids in cultured human muscle cells (7, 23) . Furthermore, irisin administration to cultured murine myocytes increased substrate oxidation, PGC-1α and irisin itself [120] . If irisin is involved in the regulation of carbo hydrate and fat metabolism, could irisin be linked to exerciseinduced substrate metabolism? Although animal studies suggested that irisin could be a potential regulator of glucose metabolism through actions on tissues such as muscle, adipose tissue and liver, the exact mechanisms (i.e. receptor, signaling pathways) of such a glucoregulatory function at rest or during exercise are still unknown [121] . However, irisin administration resulted in elevation of endothelial progenitor cells (EPCs) in the circulation, enhanced the function of bone marrow derived EPCs of diabetic mice and improved endothelial repair, suggesting that the beneficial effects of exercise on metabolic health may be mediated by irisin [122] .
Emerging evidence suggests that irisin may be implicated in the central regulation of exercise-induced neuroprotection, energy balance and glucose homeostasis. FNDC5 mRNA and FNDC5/irisin immunoreactivity have been detected in different brain areas, and it has been hypothesized that irisin could act as a messenger regulating the cross talk between muscle and brain during exercise [123] . Irisin was found to contribute to the neuroprotective effect of exercise against cerebral ischemia further supporting a role for the PGC-1a/FNDC5 axis in exercise-induced neuroprotection [92] . Furthermore, evidence indicate that irisin may inhibit food intake at hypothalamic level in a dose-dependent manner, thereby contributing to energy balance regulation [124] .
Animal studies have shown that irisin may be essential for musculoskeletal health as well. Treatment with recombinant irisin not only prevented cortical and trabecular bone loss during suspension and accelerated bone mass recovery following bone loss following suspension but also prevented muscle mass loss [125] . Interestingly, low levels of circulating irisin have been proposed as a marker for muscle dysfunction, atrophy and prediction of sarcopenia [126] . Moreover, irisin promoted osteogenesis via lineage-specific differentiation [123] and osteoblast proliferation/differentiation through P38/ERK/MAPK signaling in vitro [127] . Therefore, evidence suggests that irisin may mediate the beneficial effects of exercise on bone and muscle tissues.
In conclusion, several in vitro and animal studies support that irisin may be a potential mediator of exercise-induced beneficial adaptation on health. However, these findings need to be verified by human studies in the future.
Measurement-related issues
Although several studies provide promising evidence for irisin's metabolic role, the methodologies used to detect irisin in human or animal circulation have received some criticism due to the limited sensitivity of the commercially available enzyme-linked immunosorbent assay (ELISA) irisin kits. This criticism is mainly focused on the fact that the human FNDC5 gene has an atypical translation start codon (ATA) instead of a typical ATG codon as in mouse or rat [128] . It has been postulated that due to this codon misplacement, human FNDC5 may not even be translated, i.e. human irisin is probably a transcribed pseudogene and its synthesis is not realized in humans [49, 129] . Another study, however, reported that human irisin is mostly translated from its non-ATG start codon reaching a molecular weight like that of other biologically active peptides in humans such as leptin and insulin [95] .
The range of circulating irisin levels in healthy or unhealthy subjects varies from thousands to <1 ng/mL based on the available commercial ELISA detection kits that use polyclonal antibodies that have not been tested for cross-reactivity with other proteins (e.g. ApoA1) in serum/ plasma samples [129] . In the very first study to describe irisin, its detection was achieved by an antibody that binds to the intracellular domains of FNDC5 (hydrophobic and C-terminal) [4] , and thus the protein bands identified as irisin were probably full-length secreted FNDC5 or other proteins with affinity for this antibody thereby questioning the existence of irisin in humans [49] . This antibody was later removed and other novel antibodies binding to irisin's FNIII domain were introduced [121] . When used in Western blots, these antibodies identified protein bands ranging from ~12 kDa (the anticipated size of irisin) to 35 kDa [121] . When four commercial irisin ELISA kits were validated against Western blotting, a significant crossreactivity with non-specific proteins was revealed for human and animal serum samples [129] . Moreover, when two commercially available kits were compared, they were both able to detect an exercise-induced irisin rise in the circulation, but there was a 10-fold difference among them [25] verifying a previous study, suggesting that available ELISA kits tend to bind to various epitopes of the irisin assay [130] . Huh et al. [25] suggested that a sensitive kit for irisin measurement in blood should measure exclusively circulating irisin without containing epitopes with parts of irisin's transmembrane or intracellular domains. Interestingly, a 20-kDa FNDC5 signature that was identified by mass spectrometry in human serum samples was not detected by commercial ELISA irisin kits, suggesting that irisin data reported by previous studies using such kits may be questionable [129] . In other words, irisin measurement by such assays may be merely artifacts due to low antibody specificity even questioning the existence of irisin in human blood [129, 131, 132] . Antibodies currently used in ELISA kits for irisin detection may seriously overestimate its concentration (5-278 times) compared with data derived from mass spectrometry [133] . Unfortunately, the antibodies or antisera commonly utilized for Western blotting or ELISA assays produced numerous bands which did not correspond to the correct molecular weight of the irisin protein molecule of ~12 kDa [129] . These discrepancies may be attributed to binding of these antibodies to different domains or forms of irisin. Specifically, irisin glycocylation or deglycosylation may affect antibodies' detection potential [7, 129] .
Although most studies examining exercise-induced changes in irisin have utilized ELISA assays, the only two studies that used mass spectrometry (with a very small sample size) suggest that irisin is in fact detected in human blood. Lee et al. [7] did measure an irisin-like peptide in human plasma by mass spectrometry. Jedrychowski et al. [95] verified Lee's findings by detecting irisin in human blood using targeted mass spectrometry. These investigators synthesized their own irisin peptides that contained valine residues enriched with carbon 13. Following removal of albumin and immunoglobulins and deglycosylation of plasma samples, they identified a protein band of 12 kDa that corresponded to the size of deglycosylated irisin and verified that human irisin is translated despite the existence of the non-typical ATA start codon [95] . Irisin appeared in the blood of inactive males at a concentration of ~3.6 ng/mL, and this concentration may rise to approximately 4.3 ng/mL in response to exercise training [95] . Although this study used a very limited number of subjects (n = 6), its state-of-the-art methodology of irisin measurement provides valuable information on whether irisin exists in humans or not. However, investigators warned that irisin levels might have been underestimated due to protein loss during sample preparation [95] .
Although evidence has been provided for the existence of human irisin in the circulation, results of studies investigating its responses to exercise must be translated with caution due to limitations of commercially available analytical assays. Irisin glycosylation, the existence of irisin in various protein fragments and free or bound forms in the circulation and the extensive cross-reactivity of available antibodies with numerous protein molecules complicate the interpretation of experimental findings [134] . Future efforts need to focus on the production of monoclonal antibodies specific for various forms of irisin (e.g. non-glycosylated vs. glycosylated, free vs. bound), use of negative controls, develop proper matrix in ELISA assays, establish better guidelines for preanalytical conditions to limit treatment-related protein modification (e.g. sample preparation, optimal temperature range to prevent denaturation, storage etc.) and develop resting and exercise reference values for each irisin form [133, 134] . Scientists should also perform validation trials prior to actual study measurements [131] .
Conclusions
Because of its wide association with a great number of cytokines and receptors associated with diseases, irisin appears as a promising factor to explain numerous metabolic adaptations induced by exercise. However, future well-controlled subjects need to confirm or refute a role of irisin in exercise-induced energy metabolism. Although increased irisin release in response to administration of peroxisome proliferator-activated receptors (PPAR-α) agonists was accompanied by adipose tissue browning, reduced fat tissue and IR in obese animals is exciting and promising news, more research is needed to accept or refute a role of irisin in basal and exercise energy metabolism. It remains to fully elucidate the mode of action as well as the target tissues and end-results of irisin actions during resting and exercise conditions. A recent review concluded that even when irisin was measured with the same ELISA assay (PP, EK-067-52), it was not associated with resting energy expenditure or fatness markers [134] . The validation of ELISA and Western blot assays will aid in this aspect. A wiser approach for experimental exercise studies would be to measure not only circulating irisin but also PGC-1α, FNDC5 and UCP1 mRNA in muscle and adipose tissue. Therefore, based on the current knowledge and methodological shortcomings, this review cannot endorse a specific role for irisin in human metabolism at rest or in response to acute or chronic exercise.
